Patents by Inventor Reimi Kawaida

Reimi Kawaida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof
    Patent number: 10881734
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: January 5, 2021
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa Yoshimura, Reimi Kawaida, Kokichi Honda
  • MONOCLONAL ANTIBODIES TO HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 2 (HFGFR2) AND METHODS OF USE THEREOF
    Publication number: 20200085946
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Application
    Filed: November 19, 2019
    Publication date: March 19, 2020
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa YOSHIMURA, Reimi KAWAIDA, Kokichi HONDA
  • Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof
    Patent number: 10478496
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: November 19, 2019
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Chigusa Yoshimura, Reimi Kawaida, Kokichi Honda
  • DETECTION OF FGFR2
    Publication number: 20180133314
    Abstract: The present invention provides a pharmaceutical composition or a diagnostic composition targeting human fibroblast growth factor receptor 2 (hFGFR2).
    Type: Application
    Filed: April 19, 2016
    Publication date: May 17, 2018
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Chigusa YOSHIMURA, Reimi KAWAIDA, Kokichi HONDA
  • Anti-FGFR2 antibodies and methods of use thereof for treating cancer
    Patent number: 9714298
    Abstract: The present invention provides an antibody which binds to a fibroblast growth factor receptor.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: July 25, 2017
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Toshiaki Ohtsuka, Chigusa Yoshimura, Toshinori Agatsuma, Atsushi Urano, Takako Kimura, Yumi Matsui, Tatsuji Matsuoka, Jun Hasegawa, Yasuki Kamai, Reimi Kawaida
  • Anti-FGFR2 antibodies and pharmaceutical compositions thereof
    Patent number: 9481733
    Abstract: The present invention provides an antibody which binds to a fibroblast growth factor receptor.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: November 1, 2016
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Toshiaki Ohtsuka, Chigusa Yoshimura, Toshinori Agatsuma, Atsushi Urano, Takako Kimura, Yumi Matsui, Tatsuji Matsuoka, Jun Hasegawa, Yasuki Kamai, Reimi Kawaida
  • Anti-MST1R antibodies and uses thereof
    Patent number: 9403909
    Abstract: The present disclosure provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for MST1R, which plays an integral role in various disorders or conditions, such as cancer. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the disclosure also can be used in the diagnostics field, as well as for further investigating the role of MST1R in the progression of disorders associated with tumors. The disclosure also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: August 2, 2016
    Assignee: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Reimi Kawaida, Toshiaki Ohtsuka, Toshinori Agatsuma, Philip Rodley, Sandra Miller, Ulrike Schubert
  • ANTI-FGFR2 ANTIBODY
    Publication number: 20160009820
    Abstract: The present invention provides an antibody which binds to a fibroblast growth factor receptor.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 14, 2016
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Toshiaki Ohtsuka, Chigusa Yoshimura, Toshinori Agatsuma, Atsushi Urano, Takako Kimura, Yumi Matsui, Tatsuji Matsuoka, Jun Hasegawa, Yasuki Kamai, Reimi Kawaida
  • ANTI-FGFR2 ANTIBODY
    Publication number: 20150125454
    Abstract: The present invention provides an antibody which binds to a fibroblast growth factor receptor.
    Type: Application
    Filed: April 9, 2013
    Publication date: May 7, 2015
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Toshiaki Ohtsuka, Chigusa Yoshimura, Toshinori Agatsuma, Atsushi Urano, Takako Kimura, Yumi Matsui, Tatsuji Matsuoka, Jun Hasegawa, Yasuki Kamai, Reimi Kawaida
  • ANTI-MST1R ANTIBODIES AND USES THEREOF
    Publication number: 20120034215
    Abstract: The present disclosure provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for MST1R, which plays an integral role in various disorders or conditions, such as cancer. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the disclosure also can be used in the diagnostics field, as well as for further investigating the role of MST1R in the progression of disorders associated with tumors. The disclosure also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use.
    Type: Application
    Filed: August 10, 2011
    Publication date: February 9, 2012
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Reimi Kawaida, Toshiaki Ohtsuka, Toshinori Agatsuma, Philip Rodley, Sandra Miller, Ulrike Schubert